This is a synthetic peptide designed for use in combination with anti-BRAP Antibody(ARP43079_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BRAP
(BRCA1 Associated Protein (BRAP))
Synonyme
imp Peptide, MGC68778 Peptide, zgc:92894 Peptide, BRAP Peptide, BRAP2 Peptide, IMP Peptide, RNF52 Peptide, 3010002G07Rik Peptide, BRCA1 associated protein S homeolog Peptide, BRCA1 associated protein Peptide, BRCA1-associated protein Peptide, brca1-associated protein Peptide, brap.S Peptide, brap Peptide, BRAP Peptide, NAEGRDRAFT_81654 Peptide, CC1G_00971 Peptide, CpipJ_CPIJ003557 Peptide, Tsp_05101 Peptide, LOC100282389 Peptide, Brap Peptide
Hintergrund
The protein encoded by this gene was identified by its ability to bind to the nuclear localization signal of BRCA1 and other proteins. It is a cytoplasmic protein which may regulate nuclear targeting by retaining proteins with a nuclear localization signal in the cytoplasm.
Alias Symbols: BRAP2, IMP, RNF52
Protein Interaction Partner: BRAP,BRCA1,CENPF,CNKSR1,DDB1,HRAS,BRAP,HRAS,BRCA1,CDC14A,UBE2H